Nextech Invest, Ltd.
- SEC CIK
- 0001595430
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 15
- −1 vs. Q2 2025
- Portfolio value
- $657.0M
- +$128.6M (+24.3%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 7,601,087 | $355.0M | 54.0% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 7,162,637 | $86.0M | 13.1% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 4,055,861 | $56.7M | 8.6% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 5,533,980 | $46.5M | 7.1% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,846,409 | $20.1M | 3.1% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 340,909 | $19.3M | 2.9% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 1,113,946 | $19.0M | 2.9% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 1,408,394 | $12.0M | 1.8% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 2,915,998 | $11.6M | 1.8% | 00.0% | Unchanged | History |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $7.19M | 1.1% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,141,145 | $6.77M | 1.0% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 660,703 | $6.64M | 1.0% | −81,026−10.9% | Reduced | History |
| SLNSilence Therapeutics plc | ADS | 952,400 | $4.94M | 0.8% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COMMON STOCK | 482,689 | $3.75M | 0.6% | 00.0% | UnchangedConverted for a 1-for-25 split | History |
| BOLDBoundless Bio, Inc. | COM | 1,228,069 | $1.51M | 0.2% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (1)
Positions held at the end of Q2 2025 that are gone from this filing.